Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
24/05 | Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation | MT |
24/05 | Henlius' EU Marketing Application for Denosumab Biosimilar Accepted and Validated by Regulator | MT |
End-of-day quotes
Sector Biopharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
8.94TCr | ||||||
3.79TCr | ||||||
3.2TCr | ||||||
2.6TCr | ||||||
1.41TCr |